BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7537684)

  • 1. Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin.
    Fujii E; Irie K; Uchida Y; Ohba K; Muraki T
    Eur J Pharmacol; 1995 Feb; 273(3):267-72. PubMed ID: 7537684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin.
    Fujii E; Irie K; Uchida Y; Tsukahara F; Muraki T
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):361-4. PubMed ID: 7531292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin.
    Fujii E; Irie K; Ohba K; Ogawa A; Yoshioka T; Yamakawa M; Muraki T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):475-80. PubMed ID: 9349634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.
    Filep JG; Földes-Filep E
    Br J Pharmacol; 1993 Dec; 110(4):1347-52. PubMed ID: 8306074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin.
    Fujii E; Irie K; Ogawa A; Ohba K; Muraki T
    Eur J Pharmacol; 1996 Feb; 297(3):257-63. PubMed ID: 8666058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways.
    Sirois MG; Plante GE; Braquet P; Sirois P
    Br J Pharmacol; 1990 Dec; 101(4):896-900. PubMed ID: 2085713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways.
    Jeon SY; Kim EA; Ma YW; Kim JP; Jung TG; Hwang EG
    Ann Otol Rhinol Laryngol; 2001 Jan; 110(1):83-6. PubMed ID: 11201815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F; Calabrese R; Stati T; del Basso P
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    J Vasc Res; 2002; 39(3):238-45. PubMed ID: 12097822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
    Brkovic A; Sirois MG
    J Cell Biochem; 2007 Feb; 100(3):727-37. PubMed ID: 17115409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice.
    Fujii E; Yoshioka T; Wada K; Ishida H; Irie K; Muraki T
    Microvasc Res; 1999 Jul; 58(1):74-8. PubMed ID: 10388605
    [No Abstract]   [Full Text] [Related]  

  • 16. PGD2 is an intermediate in agonist-stimulated nitric oxide release in rabbit skin microcirculation.
    Warren JB; Loi RK; Wilson AJ
    Am J Physiol; 1994 May; 266(5 Pt 2):H1846-53. PubMed ID: 7515584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of platelet-activating factor on arteriolar and venular tone in rat trachea.
    Collins LC; Roberts AM
    Microvasc Res; 1997 Jan; 53(1):63-72. PubMed ID: 9056476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
    Alloatti G; Penna C; De Martino A; Montrucchio G; Camussi G
    Cardiovasc Res; 1999 Mar; 41(3):611-9. PubMed ID: 10435033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo.
    Warren JB; Loi RK; Coughlan ML
    Br J Pharmacol; 1993 Jul; 109(3):802-6. PubMed ID: 7689405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
    Noel AA; Fallek SR; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):661-9; discussion 669-70. PubMed ID: 8523600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.